Flow cytometry, immunohistochemistry, RNA, multiplex ELISA, immunohistochemistry and multiplex immunofluorescence analysis were used to probe the effects of MerTK expression on the tumor immune microenvironment. The gene discussed is MERTK; the disease is neoplasm.